• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DWI 是否能为 Kaiser 评分在评估乳腺病变中的应用提供额外价值。

Can DWI provide additional value to Kaiser score in evaluation of breast lesions.

机构信息

Department of Radiology, Tongde Hospital of Zhejiang Province, No. 234, Gucui Road, Xihu District, Hangzhou, 310012, Zhejiang Province, China.

出版信息

Eur Radiol. 2022 Sep;32(9):5964-5973. doi: 10.1007/s00330-022-08674-x. Epub 2022 Mar 31.

DOI:10.1007/s00330-022-08674-x
PMID:35357535
Abstract

OBJECTIVES

To explore added value of diffusion-weighted imaging (DWI) as an adjunct to Kaiser score (KS) for differentiation of benign from malignant lesions on breast magnetic resonance imaging (MRI).

METHODS

Two hundred forty-six patients with 273 lesions (155 malignancies) were included in this retrospective study from January 2015 to December 2019. All lesions were proved by pathology. Two radiologists blind to pathological results evaluated lesions according to KS. Lesions with score > 4 were considered malignant. Four thresholds of ADC values -1.3 × 10mm/s, 1.4 × 10mm/s, 1.53 × 10mm/s, and 1.6 × 10mm/s were used to distinguish benign from malignant lesions. For combined diagnosis, a lesion with KS > 4 and ADC values below the preset cutoffs was considered as malignant; otherwise, it was benign. Sensitivity, specificity, and area under the curve (AUC) were compared between KS, DWI, and combined diagnosis.

RESULTS

The AUC of KS was significantly higher than that of DWI alone (0.941 vs 0.901, p = 0.04). The sensitivity of KS (96.8%) and DWI (97.4 - 99.4%) was comparable (p > 0.05) while the specificity of KS (83.9%) was significantly higher than that of DWI (19.5-56.8%) (p < 0.05). Adding DWI as an adjunct to KS resulted in a 0-2.5% increase of specificity and a 0.1-1.3% decrease of sensitivity; however, the difference did not reach statistical significance (p > 0.05).

CONCLUSION

KS showed higher diagnostic performance than DWI alone for discrimination of breast benign and malignant lesions. DWI showed no additional value to KS for characterizing breast lesions.

KEY POINTS

• KS showed higher diagnostic performance than DWI alone for differentiation of benign from breast malignant lesions. • DWI alone showed a high sensitivity but a low specificity for characterizing breast lesions. • Diagnostic performance did not improve using DWI as an adjunct to KS.

摘要

目的

探讨弥散加权成像(DWI)作为 Kaiser 评分(KS)的附加手段,在乳腺磁共振成像(MRI)上对良恶性病变进行鉴别诊断的附加价值。

方法

本回顾性研究纳入 2015 年 1 月至 2019 年 12 月期间 246 例患者的 273 个病灶(155 个恶性病灶)。所有病灶均经病理证实。两位对病理结果不知情的放射科医生根据 KS 对病灶进行评估。评分>4 的病灶被认为是恶性的。使用四个 ADC 值阈值(-1.3×10mm/s、1.4×10mm/s、1.53×10mm/s 和 1.6×10mm/s)来区分良性和恶性病灶。对于联合诊断,如果 KS>4 且 ADC 值低于预设的截断值,则认为该病灶为恶性;否则,该病灶为良性。比较 KS、DWI 和联合诊断之间的敏感性、特异性和曲线下面积(AUC)。

结果

KS 的 AUC 显著高于 DWI 单独诊断(0.941 比 0.901,p=0.04)。KS(96.8%)和 DWI(97.4-99.4%)的敏感性相当(p>0.05),而 KS(83.9%)的特异性显著高于 DWI(19.5-56.8%)(p<0.05)。将 DWI 作为 KS 的附加手段,特异性增加了 0-2.5%,敏感性降低了 0.1-1.3%;然而,差异无统计学意义(p>0.05)。

结论

KS 对乳腺良恶性病变的鉴别诊断优于 DWI 单独诊断。DWI 对 KS 鉴别乳腺病变没有额外的价值。

关键点

  • KS 对乳腺良恶性病变的鉴别诊断优于 DWI 单独诊断。

  • DWI 单独用于描述乳腺病变时具有很高的敏感性,但特异性较低。

  • 联合使用 DWI 对 KS 并不能提高诊断性能。

相似文献

1
Can DWI provide additional value to Kaiser score in evaluation of breast lesions.DWI 是否能为 Kaiser 评分在评估乳腺病变中的应用提供额外价值。
Eur Radiol. 2022 Sep;32(9):5964-5973. doi: 10.1007/s00330-022-08674-x. Epub 2022 Mar 31.
2
Assessment of breast lesions by the Kaiser score for differential diagnosis on MRI: the added value of ADC and machine learning modeling.基于 MRI 的 Kaiser 评分对乳腺病变的鉴别诊断评估:ADC 值和机器学习建模的附加价值。
Eur Radiol. 2022 Oct;32(10):6608-6618. doi: 10.1007/s00330-022-08899-w. Epub 2022 Jun 21.
3
Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.体素内不相干运动扩散加权成像作为动态对比增强磁共振成像的辅助手段,以提高乳腺良恶性病变鉴别诊断的准确性。
Magn Reson Imaging. 2017 Feb;36:175-179. doi: 10.1016/j.mri.2016.10.005. Epub 2016 Oct 11.
4
Assessment of the contribution of the ADC value to the Kaiser score in the differential diagnosis of breast lesions with non-mass enhancement morphology on MRI.评估磁共振成像(MRI)上非肿块强化形态的乳腺病变鉴别诊断中,表观扩散系数(ADC)值对凯泽评分的贡献。
Eur J Radiol. 2024 Dec;181:111713. doi: 10.1016/j.ejrad.2024.111713. Epub 2024 Sep 1.
5
The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.联合扩散加权成像和动态对比增强 MRI 在鉴别呈洗脱曲线的良恶性乳腺病变中的作用。
Can Assoc Radiol J. 2021 Aug;72(3):460-469. doi: 10.1177/0846537120907098. Epub 2020 Mar 11.
6
Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.弥散加权成像或动态对比增强曲线:基于对比增强磁共振成像的良性和恶性乳腺病变鉴别诊断的回顾性分析。
Eur Radiol. 2020 Sep;30(9):4795-4805. doi: 10.1007/s00330-020-06883-w. Epub 2020 Apr 29.
7
The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast.动态对比增强磁共振成像联合表观扩散系数在乳腺良恶性疾病鉴别诊断中的价值。
Acta Radiol. 2022 Jul;63(7):891-900. doi: 10.1177/02841851211024002. Epub 2021 Jun 16.
8
Comparison of the diagnostic performances of diffusion parameters in diffusion weighted imaging and diffusion tensor imaging of breast lesions.扩散加权成像和扩散张量成像中扩散参数对乳腺病变诊断性能的比较。
Eur J Radiol. 2013 Dec;82(12):e801-6. doi: 10.1016/j.ejrad.2013.09.001. Epub 2013 Sep 13.
9
Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.中国女性多参数磁共振成像用于鉴别乳腺良恶性病变效用的回顾性分析
Medicine (Baltimore). 2018 Jan;97(4):e9666. doi: 10.1097/MD.0000000000009666.
10
A Multicentric Comparison of Apparent Diffusion Coefficient Mapping and the Kaiser Score in the Assessment of Breast Lesions.多中心比较表观扩散系数图与 Kaiser 评分在乳腺病变评估中的应用。
Invest Radiol. 2021 May 1;56(5):274-282. doi: 10.1097/RLI.0000000000000739.

引用本文的文献

1
External validation of multiparametric magnetic resonance imaging-based decision rules for characterizing breast lesions and comparison to Kaiser score and breast imaging reporting and data system (BI-RADS) category.基于多参数磁共振成像的乳腺病变特征描述决策规则的外部验证以及与凯泽评分和乳腺影像报告和数据系统(BI-RADS)分类的比较
Quant Imaging Med Surg. 2025 Jan 2;15(1):648-661. doi: 10.21037/qims-23-1783. Epub 2024 Dec 30.
2
Can structured integration of BI-RADS criteria by a clinical decision rule reduce the number of unnecessary biopsies in BI-RADS 4 lesions? A systematic review and meta-analysis.临床决策规则对BI-RADS标准进行结构化整合能否减少BI-RADS 4类病变中不必要的活检数量?一项系统评价与Meta分析。
Eur Radiol. 2025 Mar;35(3):1504-1513. doi: 10.1007/s00330-024-11274-6. Epub 2024 Dec 18.
3

本文引用的文献

1
A Multicentric Comparison of Apparent Diffusion Coefficient Mapping and the Kaiser Score in the Assessment of Breast Lesions.多中心比较表观扩散系数图与 Kaiser 评分在乳腺病变评估中的应用。
Invest Radiol. 2021 May 1;56(5):274-282. doi: 10.1097/RLI.0000000000000739.
2
Magnetic resonance imaging semantic and quantitative features analyses: an additional diagnostic tool for breast phyllodes tumors.磁共振成像的语义和定量特征分析:乳腺叶状肿瘤的一种辅助诊断工具。
Am J Transl Res. 2020 May 15;12(5):2083-2092. eCollection 2020.
3
The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Application of the Kaiser score on contrast-enhanced mammography in the differential diagnosis of breast lesions: comparison with breast magnetic resonance imaging.凯泽评分在乳腺造影增强检查中对乳腺病变鉴别诊断的应用:与乳腺磁共振成像的比较
Quant Imaging Med Surg. 2024 Aug 1;14(8):5541-5554. doi: 10.21037/qims-24-593. Epub 2024 Jul 18.
4
Breast lesions on MRI in mass and non-mass enhancement: Kaiser score and modified Kaiser score + for readers of variable experience.MRI上乳腺病变的肿块和非肿块强化:针对不同经验水平读者的凯泽评分和改良凯泽评分+
Eur Radiol. 2025 Jan;35(1):140-150. doi: 10.1007/s00330-024-10922-1. Epub 2024 Jul 11.
5
Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?仅基于MRI的可疑乳腺病变的定量表观扩散系数指标:有额外的临床价值吗?
Quant Imaging Med Surg. 2023 Oct 1;13(10):7092-7104. doi: 10.21037/qims-23-331. Epub 2023 Sep 12.
凯泽评分可在乳腺 MRI 高风险筛查检查中将良性能增强病变 BI-RADS 4 分类为可靠排除恶性肿瘤。
Eur Radiol. 2020 Nov;30(11):6052-6061. doi: 10.1007/s00330-020-06945-z. Epub 2020 Jun 6.
4
Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.弥散加权成像或动态对比增强曲线:基于对比增强磁共振成像的良性和恶性乳腺病变鉴别诊断的回顾性分析。
Eur Radiol. 2020 Sep;30(9):4795-4805. doi: 10.1007/s00330-020-06883-w. Epub 2020 Apr 29.
5
Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.弥散加权成像及其表观扩散系数图在动态对比增强 MRI 呈非肿块样强化的乳腺病变中的作用有限。
Breast Cancer Res. 2019 Dec 4;21(1):136. doi: 10.1186/s13058-019-1208-y.
6
Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.Kaiser 评分对乳腺 MRI 检查 BI-RADS 4 类乳腺钙化临床决策的影响。
Eur Radiol. 2020 Mar;30(3):1451-1459. doi: 10.1007/s00330-019-06444-w. Epub 2019 Dec 3.
7
Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group.乳腺弥散加权成像的共识和任务声明:来自 EUSOBI 国际乳腺弥散加权成像工作组。
Eur Radiol. 2020 Mar;30(3):1436-1450. doi: 10.1007/s00330-019-06510-3. Epub 2019 Nov 30.
8
Breast MRI in the era of diffusion weighted imaging: do we still need signal-intensity time curves?弥散加权成像时代的乳腺 MRI:我们仍然需要信号强度时间曲线吗?
Eur Radiol. 2020 Jan;30(1):47-56. doi: 10.1007/s00330-019-06346-x. Epub 2019 Jul 29.
9
A Meta-analysis of the Diagnostic Performance of Diffusion MRI for Breast Lesion Characterization.磁共振弥散成像对乳腺病变特征诊断性能的 Meta 分析。
Radiology. 2019 Jun;291(3):632-641. doi: 10.1148/radiol.2019182510. Epub 2019 Apr 23.
10
Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).扩散加权成像在减少乳腺 MRI 引导的不必要活检中的应用:ECOG-ACRIN 癌症研究组(A6702)的一项试验。
Clin Cancer Res. 2019 Mar 15;25(6):1756-1765. doi: 10.1158/1078-0432.CCR-18-2967. Epub 2019 Jan 15.